Mortality Reduction After Oral Azithromycin: Mortality Study

PHASE4CompletedINTERVENTIONAL
Enrollment

190,238

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

September 30, 2018

Study Completion Date

September 30, 2018

Conditions
Childhood Mortality
Interventions
DRUG

Azithromycin

Children aged 1 month to 60 months per community will be offered weight or height-based, directly observed, oral azithromycin suspension every 6 months for 2 years. In Niger during year 3, all communities will be offered azithroymcin.

DRUG

Placebo

Children aged 1 month to 60 months per community will be offered weight or height-based, directly observed, oral placebo every 6 months for 2 years. In Niger during year 3, all communities will be offered azithroymcin.

Trial Locations (6)

21205

Johns Hopkins University, Baltimore

94143

UCSF Proctor Foundation, San Francisco

Unknown

College of Medicine at the University of Malawi, Blantyre, Blantyre

The Carter Center, Niger, Niamey

Kongwa Trachoma Project, Kongwa

London School of Hygiene & Tropical Medicine, London

All Listed Sponsors
collaborator

Bill and Melinda Gates Foundation

OTHER

collaborator

Johns Hopkins University

OTHER

collaborator

London School of Hygiene and Tropical Medicine

OTHER

lead

University of California, San Francisco

OTHER

NCT02047981 - Mortality Reduction After Oral Azithromycin: Mortality Study | Biotech Hunter | Biotech Hunter